Observational and trial data suggest HCQ reduces recurrence of antibody‐mediated cardiac neonatal lupus/CHB and is recommended as prophylaxis in women with anti‐Ro/SSA antibodies, particularly with prior affected offspring [6]. This evidence concerns the gene TRIM21 and systemic lupus erythematosus.